The government has released further guidance relating to COVID-19 and has announced it will be sending letters out to 1.5 million people in England deemed most vulnerable due to health conditions....
A new study has found that people who experience a relapse from multiple sclerosis (MS) tend to see a decline in cognitive test scores, and sometimes don’t experience a full recovery.
A team of...
A group of medical advisors for the MS Society, which includes some of the leading neurologists in the UK, have agreed the following joint statement on the COVID-19 coronavirus and MS:
“We have been...
As many as one in six carers for people with multiple sclerosis (MS) are working for more than 90 hours a week, a survey by the MS Society has found.
Out of 549 respondents to the survey, all of whom...
Peginterferon beta-1a has been recommended as a treatment option for relapsing remitting multiple sclerosis (RRMS) by The National Institute for Health and Care Excellence (NICE) for use on the NHS...
A team of researchers has been given more than £5 million of funding to develop new medication to help treat multiple sclerosis (MS).
Pheno Therapeutics aims to build on the work of University of...
People with dysphagia, which is a difficulty in swallowing, may live up to two years longer if they have a feeding tube before the age of 50, a new study has found.
It’s estimated around 30% of...
Progressive cognitive decline for people with multiple sclerosis (MS) may not be as inevitable as once thought, a new 10-year study has found.
The study even found that for some patients, a ‘bouncing...
Reducing dietary intake of the amino acid methionine might delay the onset and progression of inflammatory and autoimmune disorders like multiple sclerosis (MS), according to a new study.
In MS, the...
Insomnia is playing an unwelcome part in the lives of people living with multiple sclerosis (MS), with 85% of MSers experiencing sleeplessness, according to research from social network and charity...
